Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption (Q30814535)

26 June 2017

title

Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption (English)

1 reference

26 June 2017

1 reference

dilated cardiomyopathy

1 reference

7

Gerd Wallukat

1 reference

26 June 2017

Klaus-Dieter Wernecke

8

object named as

Klaus D Wernecke

1 reference

26 June 2017

Stephan B Felix

1

1 reference

26 June 2017

Alexander Staudt

2

1 reference

26 June 2017

Martin Landsberger

3

1 reference

26 June 2017

Yvonne Grosse

4

1 reference

26 June 2017

Verena Stangl

5

1 reference

26 June 2017

Thomas Spielhagen

6

1 reference

26 June 2017

Gert Baumann

9

1 reference

26 June 2017

Karl Stangl

10

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Journal of the American College of Cardiology

26 June 2017

published in

1 reference

26 June 2017

volume

39

1 reference

26 June 2017

issue

4

1 reference

26 June 2017

page(s)

646-652

1 reference

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Elevated circulating levels of beta 2-microglobulin in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

A synthetic peptide corresponding to the second extracellular loop of the human M2 acetylcholine receptor induces pharmacological and morphological changes in cardiomyocytes by active immunization after 6 months in rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Myocarditis: the Dallas criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Soluble substances released from postischemic reperfused rat hearts reduce calcium transient and contractility by blocking the L-type calcium channel.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

1 reference

7 January 2021

Advances in the understanding of myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Immunohistochemistry in dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Recent insights into the role of tumor necrosis factor in the failing heart.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901794-6

7 January 2021

10.1016/S0735-1097(01)01794-6

Identifiers

DOI

1 reference

release_6a3u6v6w3vehha73bqqati5e5u

26 June 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6a3u6v6w3vehha73bqqati5e5u

24 November 2022

mapped directly with Wikidata item

1 reference